Tormund S. Njølstad

Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial

Jone Trovik, Elisabeth Wik, Henrica M.J. Werner et al. · European Journal of Cancer · 2013 · 151 citations

Stathmin Overexpression Identifies High-Risk Patients and Lymph Node Metastasis in Endometrial Cancer

Jone Trovik, Elisabeth Wik, Ingunn M. Stefansson et al. · Clinical Cancer Research · 2011 · 118 citations

Preoperative anemia, leukocytosis and thrombocytosis identify aggressive endometrial carcinomas

Tormund S. Njølstad, Hilde Engerud, Henrica M.J. Werner et al. · Gynecologic Oncology · 2013 · 83 citations

Gynecological Surgery, Aggressive Endometrial Carcinomas, Medicine +5

CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancer

Deborah J. Thompson, Tracy A. O’Mara, Dylan M. Glubb et al. · Endocrine Related Cancer · 2015 · 68 citations · Full text

High BMI is significantly associated with positive progesterone receptor status and clinico-pathological markers for non-aggressive disease in endometrial cancer

Karen K. Mauland, Jone Trovik, Elisabeth Wik et al. · British Journal of Cancer · 2011 · 55 citations · Full text